Literature DB >> 18191842

Clomiphene citrate and intrauterine insemination: analysis of more than 4100 cycles.

Serena Dovey1, Rita M Sneeringer, Alan S Penzias.   

Abstract

OBJECTIVE: To evaluate the outcomes of a large cohort of patients undergoing fertility treatment with clomiphene citrate and intrauterine insemination.
DESIGN: A retrospective cohort study.
SETTING: Boston IVF, a large university-affiliated reproductive medicine practice. PATIENT(S): A total of 4,199 cycles performed in 1,738 infertility patients between September 2002 and July 2007. INTERVENTION(S): All patients received oral clomiphene citrate, and patients with completed cycles had intrauterine insemination performed. MAIN OUTCOME MEASURE(S): Cumulative and per cycle pregnancy rates achieved among subsets of patients defined by age, completed cycles, and intention to treat (ITT). RESULT(S): For women under age 35 years, 2,351 cycles were initiated in 983 patients. A total of 238 pregnancies ensued, yielding a pregnancy rate (PR) per completed cycle of 11.5% and 10.1% per cycle initiated with ITT. In women aged 35-37 years, 947 cycles in 422 women lead to a PR per completed cycle and ITT of 9.2% and 8.2%, respectively. For patients aged 38-40 years, 614 cycles in 265 women lead to a PR per completed cycle and ITT of 7.3% and 6.5%, respectively. In women aged 41-42 years, 166 cycles in 81 patients lead to a PR per completed cycle and ITT of 4.3% and 3.6%, respectively. For women above age 42 years, 120 cycles in 55 patients lead to a PR per completed cycle and ITT of 1.0% and 0.8%, respectively. On a per-patient treated basis, cumulative PRs were 24.2% under age 35, 18.5% ages 35-37, and 15.1% ages 38-40, whereas only 7.4% ages 41-42 and 1.8% above 42 became pregnant (one pregnancy in 55 patients). CONCLUSION(S): As anticipated, younger patients have a higher PR per cycle than older patients. The PR per cycle for patients who initiate only one or only two treatment cycles is notably higher than the corresponding per cycle rates for cycles 3 through 9. The drop in success per patient among 41- and 42-year-olds is sharp, but the exceptionally low success rate above age 42 suggests that CC with IUI has virtually no place in their treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18191842     DOI: 10.1016/j.fertnstert.2007.10.057

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

Review 1.  Predicting suitable timing for artificial reproductive technology treatment in aged infertile women.

Authors:  Nana Akino; Wataru Isono; Osamu Wada-Hiraike
Journal:  Reprod Med Biol       Date:  2016-03-29

Review 2.  Ovulation induction and intrauterine insemination in women of advanced reproductive age: a systematic review of the literature.

Authors:  Carleigh B Nesbit; Misty Blanchette-Porter; Navid Esfandiari
Journal:  J Assist Reprod Genet       Date:  2022-06-22       Impact factor: 3.357

Review 3.  What is the best treatment option for infertile women aged 40 and over?

Authors:  Sarah Armstrong; Valentine Akande
Journal:  J Assist Reprod Genet       Date:  2013-03-29       Impact factor: 3.412

4.  Acceptable pregnancy rate of unstimulated intrauterine insemination: a retrospective analysis of 17,830 cycles.

Authors:  Tetsuro Honda; Mai Tsutsumi; Fumio Komoda; Kenichi Tatsumi
Journal:  Reprod Med Biol       Date:  2014-08-21

Review 5.  Predictive factors for intrauterine insemination outcomes: a review.

Authors:  Anabel Starosta; Catherine E Gordon; Mark D Hornstein
Journal:  Fertil Res Pract       Date:  2020-12-11

6.  Alternative strategies to in vitro fertilization/intracytoplasmic sperm injection treatment for aged infertile women.

Authors:  Wataru Isono; Osamu Wada-Hiraike; Akira Shirane; Akihisa Fujimoto; Yutaka Osuga; Tetsu Yano; Yuji Taketani
Journal:  Reprod Med Biol       Date:  2011-08-13

Review 7.  Diagnosis and Management of Infertility: A Review.

Authors:  Sandra Ann Carson; Amanda N Kallen
Journal:  JAMA       Date:  2021-07-06       Impact factor: 157.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.